Opdualag 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued 2 / 
affected 3  
amended 
on 
IB/0007 
B.I.b.1.z - Change in the specification parameters 
09/02/2024 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
IB/0006 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
08/01/2024 
n/a 
period/storage period - Extension or introduction of a 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
re-test period/storage period supported by real time 
data 
N/0004 
Minor change in labelling or package leaflet not 
15/11/2023 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/11018
Periodic Safety Update EU Single assessment - 
26/10/2023 
n/a 
PRAC Recommendation - maintenance 
/202303 
nivolumab / relatlimab 
IA/0002/G 
This was an application for a group of variations. 
15/05/2023 
n/a 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
IB/0001/G 
This was an application for a group of variations. 
06/03/2023 
n/a 
B.II.d.1.d - Change in the specification parameters 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
Page 2/3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 3/3 
 
 
 
 
 
 
